Does CABOZANTINIB S-MALATE Cause Pulmonary embolism? 345 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 345 reports of Pulmonary embolism have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.9% of all adverse event reports for CABOZANTINIB S-MALATE.
345
Reports of Pulmonary embolism with CABOZANTINIB S-MALATE
0.9%
of all CABOZANTINIB S-MALATE reports
50
Deaths
216
Hospitalizations
How Dangerous Is Pulmonary embolism From CABOZANTINIB S-MALATE?
Of the 345 reports, 50 (14.5%) resulted in death, 216 (62.6%) required hospitalization, and 25 (7.2%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Pulmonary embolism Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE